Seeking Alpha

Cempra (CEMP) announces its intention to launch a public offering. The proceeds from the...

Cempra (CEMP) announces its intention to launch a public offering. The proceeds from the potential deal will go towards the "Phase 3 clinical trial of solithromycin in community acquired bacterial pneumonia." In a separate PR, CEMP described the steps it will need to take to get the treatment approved.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|